News FDA approves new uses for two Roche drugs FDA hands out new indications for Tecentriq and Lucentis.
News Opdivo still clear immunotherapy leader despite Keytruda gai... Immunotherapy takes on rivals from Roche and BMS.
News Roche's Tecentriq approved for UK early access Tecentriq is latest immunotherapy available on the scheme.
Roche Roche muscling into melanoma with Tecentriq Swiss pharma looking to combine immunotherapy with already marketed drugs.
Cancer Positive results for Pacific Edge's bladder cancer diagnosti... Cancer diagnostic company Pacific Edge has revealed positive trial results for its Cxbladder Monitor gene expression test.
Market Access Consolidating data strategy for global success: Insights fro... At Frontiers Health 2025, Drew McCormick, Head of Data and Analytics at EVERSANA, emphasised a critical truth: data strategy is launch strategy.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
